At a glance
ClinicalIndex Comparison RecordN/ACompleted· 57 enrolled
Drug / intervention
TrueTeardevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Single-Arm Clinical Trial to Evaluate Acute Dry Eye Symptom Relief Assessed During Exposure to a Controlled Adverse Environment (CAE®) Following a 45 Day Period With Application of TrueTear™
In Brief
A clinical study evaluating TrueTear for Dry Eye and Dry Eye Syndromes. Completed, enrolled 57 participants across 1 site.
Detailed Summary
This study characterizes acute dry eye symptom control, assessed during exposure to a Controlled Adverse Environment, following use of the TrueTear for 45 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye, Dry Eye Syndromes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 2017
Enrollment StartMar 2017
Primary CompletionJun 2017
TodayJul 2026
First PostedMar 31, 2017
Enrollment StartMar 31, 2017
Primary CompletionJun 26, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.3 years ago
Interventions
TrueTeardevice
The device delivers small electrical currents, activating nerves that stimulate the body's natural tear production system.